
Navigating earnings risk in megacap tech, and a buying opportunity in this industrial name
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNBC
a minute ago
- CNBC
Nvidia's China-bound H20 AI chips face Beijing scrutiny over ‘tracking' and security concerns
While Nvidia has been given assurances by Washington that it will be allowed to resume exports of its made-for-China H20 general processing units, the AI chips may be met with increased scrutiny from Beijing. According to the Cyberspace Administration of China, Nvidia met with Beijing officials on Thursday regarding potential national security concerns posed by its H20 chips, which recently saw restrictions on their export lifted following an effective ban in April. Nvidia was requested "to clarify and submit relevant supporting documentation regarding security risks, including potential vulnerabilities and backdoors, associated with its H20 computing chips sold to China," according to a CNBC translation of a statement from CAC. In a post, the regulator said that Nvidia's computing chips were reported to have serious security vulnerabilities, also noting calls from U.S. lawmakers for mandatory tracking features to be placed on advanced chips exported from the country. In its statement, CAC added that American AI experts had already revealed that Nvidia's computing chips pose mature "tracking and positioning" and "remote shutdown" technologies. The statement appears to be referencing a report from Reuters in May that said Bill Foster, a Democrat lawmaker from Illinois, was planning to introduce legislation that would require advanced AI chipmakers like Nvidia to include a built-in location reporting system. Forester, who once worked as a particle physicist, and independent technical experts reportedly agreed that the technology to track chips was readily available, with much of it already built into Nvidia's chips. Forester's bill would also seek to give U.S. authorities the power to remotely shut down chips being used without proper licenses, in a measure to fight chip smuggling and export loopholes. Nvidia did not immediately respond to a request for comment from CNBC. In recent weeks, many American lawmakers have also taken issue with the reported rollback of restrictions on Nvidia's H20 chips, warning they will advance Beijing's AI capability. This week, Nvidia reportedly placed orders for 300,000 H20 chipsets with contract manufacturer TSMC as it seeks to meet Chinese demand.


Business Upturn
an hour ago
- Business Upturn
Why Dr. Reddy's shares are down nearly 2% today? Explained
By Aditya Bhagchandani Published on July 31, 2025, 09:44 IST Shares of Dr. Reddy's Laboratories Ltd dropped nearly 2% to ₹1,269.70 in early trade on Wednesday, reacting sharply to the overnight announcement by former U.S. President Donald Trump regarding the imposition of 25% tariffs on Indian exports to the United States. The move includes a yet-unspecified penalty for India's continued energy and defense dealings with Russia. The stock was among the worst-hit in the pharmaceutical space as investors digested the potential impact on generic drug exports, which constitute a major portion of India's pharmaceutical trade with the U.S. Pharma Exports at Risk? The United States is a critical market for Indian drugmakers. In fact, Dr. Reddy's derives 46% of its revenue from the U.S., making it highly sensitive to any changes in trade policy. While pharmaceuticals are currently exempt from the reciprocal tariff list (announced in April), officials from the White House confirmed to CNBC-TV18 that these exemptions may soon be lifted. The Department of Commerce's Section 232 investigation into Indian generic drug exports has now concluded, and according to Trump's latest statement, tariffs on pharma 'are coming soon.' Currently, India pays zero tariffs on generic drug exports to the U.S. If the proposed 25% tariff is applied to this sector, Indian companies may have to choose between: Passing the cost onto U.S. consumers , making Indian generics less price-competitive Reevaluating U.S. portfolios , withdrawing lower-margin or loss-making products Manufacturing in the U.S., which may offer no cost advantage for generics Broader Impact Across the Pharma Space Besides Dr. Reddy's, stocks likely to remain under pressure include: Sun Pharma (33% U.S. exposure) Aurobindo Pharma (45%) Gland Pharma (53%) Divi's Laboratories Cipla, Lupin, and Biocon Who Might Buck the Trend? Pharma firms and healthcare providers with a domestic business focus or minimal U.S. exposure may remain resilient: Ajanta Pharma, Eris Lifesciences, Torrent Pharma Apollo Hospitals, Fortis Healthcare, Aster DM Diagnostics players like Dr. Lal Pathlabs, Metropolis Final Word Though Indian pharma exports are not yet officially included in the tariff list, Trump's statements have created uncertainty for the sector. Until there is clarity from the U.S. Trade Representative or India's Commerce Ministry, investor sentiment around high U.S.-exposed pharma names may remain volatile. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.


CNBC
2 hours ago
- CNBC
European markets head for broadly higher open as earnings deluge continues
The Millennium Bridge in London, on July 4, 2025. Jonathan Brady - Pa Images | Pa Images | Getty Images Good morning from London, and welcome to CNBC's live blog covering all the action and business news in European financial markets on Thursday. Futures data from IG suggest a broadly positive open for European indexes, with London's FTSE 100 seen opening 0.1% higher, France's CAC 40 unchanged, Germany's DAX up 0.2%, and Italy's FTSE MIB 0.3% higher. European markets closed in mixed territory Wednesday, with sectors diverging as second-quarter earnings season ramped up. There will be more earnings today, with Unilever , Shell , Anheuser-Busch Inbev, London Stock Exchange Group , BMW , Anglo American , SocGen , Renault , AF-KLM , Euronext, Sanofi, Credit Agricole and ArcelorMittal among the heavyweight regional companies that are due to report. On the data front, French, German and Italian inflation data is due, as are the latest German and EU unemployment figures. — Holly Ellyatt